Search research articles
Contact Us
Filters
Showing results (641-650 of 764) with videos related to
Page
of 77
Sort By:
BMC Psychiatry
|
July 9, 2016
Associations between personality disorder characteristics and treatment outcomes in people with co-occurring alcohol misuse and depression
Kristen L McCarter, Sean A Halpin, Amanda L Baker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 14, 2003
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12
Bohuslav Melichar, Renato Lenzi, Michael Rosenblum, et al.
Gynecologic Oncology
|
July 1, 1995
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer
J J Kavanagh, C L Edwards, R S Freedman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 28, 2019
Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion
Megan E Martin, Denise K Reaves, Breanna Jeffcoat, et al.
Cancer
|
June 1, 1987
Intrahepatic infusional therapy for metastatic ovarian carcinoma
J M Malone, D M Gershenson, C H Carrasco, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 10, 2020
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer
Anca Chelariu-Raicu, Charles F Levenback, Brian M Slomovitz, et al.
Free Radical Biology & Medicine
|
May 29, 2012
Transforming growth factor β suppresses glutamate-cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model
Rui-Ming Liu, Praveen Kumar Vayalil, Carol Ballinger, et al.
Gynecologic Oncology
|
April 14, 2009
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
David M Gershenson, Charlotte C Sun, Diane Bodurka, et al.
Journal of Hematology & Oncology
|
March 13, 2010
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
John J Kavanagh, Charles F Levenback, Pedro T Ramirez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Retinoic acid and interferon combination studies in human cancer
S M Lippman, B S Glisson, J J Kavanagh, et al.
Page
of 77
Search research articles
Search
Showing results (641-650 of 764) with videos related to
Sort By:
Page
of 77
BMC Psychiatry
|
July 9, 2016
Associations between personality disorder characteristics and treatment outcomes in people with co-occurring alcohol misuse and depression
Kristen L McCarter, Sean A Halpin, Amanda L Baker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 14, 2003
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12
Bohuslav Melichar, Renato Lenzi, Michael Rosenblum, et al.
Gynecologic Oncology
|
July 1, 1995
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer
J J Kavanagh, C L Edwards, R S Freedman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
July 28, 2019
Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion
Megan E Martin, Denise K Reaves, Breanna Jeffcoat, et al.
Cancer
|
June 1, 1987
Intrahepatic infusional therapy for metastatic ovarian carcinoma
J M Malone, D M Gershenson, C H Carrasco, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 10, 2020
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer
Anca Chelariu-Raicu, Charles F Levenback, Brian M Slomovitz, et al.
Free Radical Biology & Medicine
|
May 29, 2012
Transforming growth factor β suppresses glutamate-cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model
Rui-Ming Liu, Praveen Kumar Vayalil, Carol Ballinger, et al.
Gynecologic Oncology
|
April 14, 2009
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
David M Gershenson, Charlotte C Sun, Diane Bodurka, et al.
Journal of Hematology & Oncology
|
March 13, 2010
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
John J Kavanagh, Charles F Levenback, Pedro T Ramirez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Retinoic acid and interferon combination studies in human cancer
S M Lippman, B S Glisson, J J Kavanagh, et al.
Page
of 77